OMAXE vs MOLBIO: Stock Comparison
Head-to-head financial and trading comparison between Omaxe Limited (OMAXE) and Molbio Diagnostics Limited (MOLBIO) in the Cross-Sector Peers sector.
OMAXE
NSE: OMAXEMOLBIO
NSE: MOLBIOKey Metrics Comparison Table
| Metric | OMAXE | MOLBIO | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹100.19 | ₹1,438.60 | — |
| 1-Year Price Return | +27.02% | +38.1% | MOLBIO (11.08% higher) |
| 52-Week High | ₹136.38 | ₹1,544.70 | — |
| 52-Week Low | ₹73.17 | ₹1,036.65 | — |
| 30-Day Annualized Volatility | 76.35% | 95.93% | OMAXE (Steadier) |
| 30-Day Average Daily Volume | 4,478,010 | 3,210,458 | OMAXE (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between OMAXE and MOLBIO, which stock gave better returns over the last year?
MOLBIO has outperformed OMAXE over the past 12 months with a gain of 38.1% compared to 27.02%.
Which stock is less volatile: OMAXE or MOLBIO?
OMAXE demonstrated lower price volatility (76.35% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of OMAXE vs MOLBIO?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are OMAXE and MOLBIO direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.